相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe
Noah H. Paul et al.
ACTA TROPICA (2016)
Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens
Jonathan J. Juliano et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2016)
An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines
Kazutoyo Miura et al.
MALARIA JOURNAL (2016)
Naturally acquired immunity to sexual stage P. falciparum parasites
Will J. R. Stone et al.
PARASITOLOGY (2016)
A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
Sodiomon B. Sirima et al.
VACCINE (2016)
Synthetic TLR4 agonists enhance functional antibodies and CD4+T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen
Susan L. Baldwin et al.
VACCINE (2016)
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Susan Thrane et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45
Michael Pritsch et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Karl D. Brune et al.
SCIENTIFIC REPORTS (2016)
Toward the development of effective transmission-blocking vaccines for malaria
Daria Nikolaeva et al.
EXPERT REVIEW OF VACCINES (2015)
Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates
Sophie Jones et al.
JOURNAL OF INFECTION (2015)
Transmission- blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants
Will Roeffen et al.
MALARIA JOURNAL (2015)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies
Susheel K. Singh et al.
VACCINE (2015)
Recent advances in recombinant protein-based malaria vaccines
Simon J. Draper et al.
VACCINE (2015)
Development of a Single-Replicon miniBYV Vector for Co-expression of Heterologous Proteins
Alex Prokhnevsky et al.
MOLECULAR BIOTECHNOLOGY (2015)
Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum
M. C. Kapulu et al.
SCIENTIFIC REPORTS (2015)
A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages
Michael Theisen et al.
VACCINE (2014)
Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii
Carla S. Jones et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm
Julie Lobstein et al.
MICROBIAL CELL FACTORIES (2012)
Lactococcus lactis-based vaccines from laboratory bench to human use: An overview
Mohammed Bahey-El-Din
VACCINE (2012)
Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura
Meral Esen et al.
VACCINE (2012)
Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs48/45 and Pfs230 in an Area of Seasonal Transmission
Andre Lin Ouedraogo et al.
INFECTION AND IMMUNITY (2011)
Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulfide bond containing proteins expressed in the cytoplasm of E-coli
Van Dat Nguyen et al.
MICROBIAL CELL FACTORIES (2011)
A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children
Sabine Belard et al.
PLOS ONE (2011)
Vaccines against malaria
Adrian V. S. Hill
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2011)
A Research Agenda to Underpin Malaria Eradication
Pedro L. Alonso et al.
PLOS MEDICINE (2011)
Experimental human challenge infections can accelerate clinical malaria vaccine development
Robert W. Sauerwein et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania
Teun Bousema et al.
PLOS ONE (2010)
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon
Benjamin Mordmueller et al.
VACCINE (2010)
Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia
Karen I. Barnes et al.
MALARIA JOURNAL (2009)
A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli
Debabani Roy Chowdhury et al.
PLOS ONE (2009)
Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development
Shannon L. Takala et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
Ruth D. Ellis et al.
VACCINE (2009)
Safety and immunogenicity of GMZ2-a MSP3-GLURP fusion protein malaria vaccine candidate
Meral Esen et al.
VACCINE (2009)
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis
Serign J. Ceesay et al.
LANCET (2008)
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
Yimin Wu et al.
PLOS ONE (2008)
Correctly folded MUM protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice
Nikolay S. Outchkourov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Epitope analysis of the malaria surface antigen Pfs48/45 identifies a subdomain that elicits transmission blocking antibodies
Nikolay Outchkourov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults
J. T. Bousema et al.
PARASITE IMMUNOLOGY (2007)
Protein disulfide isomerase assisted protein folding in malaria parasites
B. Mahajan et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2006)
Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production
Saliha Eksi et al.
MOLECULAR MICROBIOLOGY (2006)
Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers
CJ Drakeley et al.
PARASITE IMMUNOLOGY (2006)
A Plasmodium falciparum GLURP-MSP3 chimeric protein;: expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies
M Theisen et al.
VACCINE (2004)
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1):: Production and activity of an AMA1 vaccine and generation of a multiallelic response
MC Kennedy et al.
INFECTION AND IMMUNITY (2002)
Extreme geographical fixation of variation in the Plasmodium falciparum gamete surface protein gene Pfs48/45 compared with microsatellite loci
DJ Conway et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum
WFG Roeffen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A central role for P48/45 in malaria parasite male gamete fertility
MR van Dijk et al.
CELL (2001)
Plasmodium falciparum: Production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen
W Roeffen et al.
EXPERIMENTAL PARASITOLOGY (2001)
Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast
RLB Milek et al.
VACCINE (2000)
分享论文
